If you cannot view the eLetter, or the links do not work, you can read it on the Web at http://www.scleroderma.org/e-letters/eLetter_124.htm. If someone has forwarded this eLetter to you, and you wish to subscribe to this FREE weekly publication, go to http://www.scleroderma.org/e_letter_signup.shtm.

Scleroderma Foundation logo

Email Us

Free Info Packet

Calendar

Magazine

Chat

Medical Archive

Support SF

SF Store

SF Home Page


 
  Medical Archive
Lise Gloede, R.D., speaking at the 2003 National Conference.

Lise Gloede, R.D., speaking at the 2003 National Conference.

Eating Well: Nutritional Needs in Scleroderma

By Lise Gloede, Registered Dietician (originally published in "Scleroderma Voice," 2001, #4)

The purpose of this article is to identify nutritional needs in scleroderma and provide practical food advice, with the two goals of minimizing nutrition-related side effects and to improve your overall nutritional health.

 

Scleroderma Foundation E-Letter

Friday, January 13, 2006– Issue #124

eLetter Archive
Joseph P. Camerino, Ph.D.

Dr. Joseph P. Camerino Ascends to the Chairmanship of the Scleroderma Foundation

DANVERS, Mass. – Joseph P. Camerino, Ph.D., of Baldwinsville, N.Y. was elected the new Chair of the Board for the Scleroderma Foundation at the December board meeting. His two-year term began Jan. 1.

Novagali Pharma Reports Successful Completion of Phase II Clinical Study of Cyclosporine A for Dry Eye Syndrome

Novagali Logo

Novagali Pharma has reported the successful completion of a Phase II clinical study of its ophthalmic formulation of Cyclosporine A. The results demonstrate the safety of Nova22007 in patients suffering from Sjögren syndrome associated with keratoconjunctivitis sicca (dry eye syndrome), and indicate trends towards efficacy. Nova22007 is a proprietary cationic emulsion enabling an optimal penetration of Cyclosporine A in tissues of the eye surface.

Sjögren’s Syndrome Foundation to Hold Regional Patient Seminar in Minneapolis On March 31–April 1

Sjogren's Syndrome Foundation Logo

BETHESDA, Maryland – The Sjögren’s Syndrome Foundation, the recognized advocate for Sjögren’s Syndrome, will have a regional seminar designed to educate and serve Sjögren’s patients and their families in the upper Midwest.

FDA Safety Change – Lisinopril Tablets (Prinivil) Linked Rarely to Head/Neck Angoiedema and Hepatic Failure

FDA logo

On October 5, the FDA approved safety labeling revisions for lisinopril tablets (Prinivil, made by Merck & Co, Inc.) to warn of the rare risk for head/neck angioedema and hepatic failure associated with its use.

Stepping Out to Cure Scleroderma Walks Gearing Up!

Sjogren's Syndrome Foundation Logo

If you didn't walk last year you missed out on a ton of fun! Check out our walk page, learn about the event, and find a walk near you.

Get Connected Bulletin BoardYou Can Post Messages Any Time On Our "Get Connected" Bulletin Board

In addition to our nationwide network of Chapters and Support Groups, we offer you electronic ways to connect with other people.

Upcoming Events

Jan. 14 (Sat.): Texas Bluebonnet Chapter Hosts Medical Workshop. (Houston, Texas)

Jan. 21 (Sat.): Cooking Up a Storm for Scleroderma. (Ocala, Fla.)

Scleroderma Foundation, 300 Rosewood Drive, Suite 105, Danvers, MA 01923
Phone 978-463-5843 · 800-722-HOPE (4673) · Email: sfinfo@scleroderma.org

© Copyright 2006 Scleroderma Foundation. All Rights Reserved.
Disclaimer. Privacy Policy.